| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Executive Chairman
3 companies
Doyle William F serves as an Executive Chairman at NVCR and has filed Form 4s across 3 companies. Across recent SEC filings that breaks down to 13 buys and 49 sells. Those positions are worth an estimated $12.0M at current prices.
Historically, Doyle William F's trades have earned a middling insider score of 53/100 across 7 rated trades. Over a 12-month horizon, 57.1% of those trades were profitable, with an average 12-month return of +19.7%.
The biggest single holding is NVCR (~$9.7M) as Executive Chairman. The recent filings there lean toward selling, a net 821,523 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 14, 2018 | NERV Minerva Neurosciences, Inc. | Director | Buy | 2,200 | $10.50 | $23,100.00 | +12.2% | |
| Sep 11, 2018 | NERV Minerva Neurosciences, Inc. | Director | Buy | 8,011 | $9.80 | $78,506.92 | +200.3% |